Approved Nanomedicine against Diseases

Area of Science:

• Nanomedicine
• Biotechnology
• Materials Science

Background:

• Nanotechnology offers significant advantages in drug delivery, improving solubility, biodistribution, and controlled release.
• The application of nanotechnology in medicine has revolutionized the treatment of major diseases, including cancer and cardiovascular diseases.
• Despite rapid growth, clinical translation of nanomedicine faces challenges, with traditional formulations still prevalent.

Purpose of the Study:

• To review approved nanomedicine products and their therapeutic indications.
• To summarize the properties of commonly employed nanocarriers and nanotechnology in drug delivery.
• To highlight the impact of nanomedicine on disease treatment and drug formulation.

Main Methods:

• Literature review of approved nanomedicine.
• Analysis of nanocarrier properties and nanotechnology applications.
• Synthesis of information on nanomedicine's role in disease treatment.

Main Results:

• Nanomedicine enhances drug efficacy and reduces toxicity through improved pharmacokinetics.
• Nanoscale drug formulations are increasingly used for conditions like cancer and cardiovascular diseases.
• A summary of approved nanomedicines, their uses, and carrier properties is provided.

Conclusions:

• Nanomedicine represents a transformative approach in modern medicine, offering improved therapeutic outcomes.
• Continued research and development in nanocarriers and nanotechnology are crucial for clinical translation.
• The trend towards nanoscale drug delivery systems is expected to grow, impacting future pharmaceutical development.